The Patent Finder

Process for Manufacturing Glatiramer Acetate Product

Teva Pharmaceutical Industries, Ltd.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,155,775Process for Manufacturing Glatiramer Acetate Product
In force
 · High confidence
UsedRemaining
Teva Pharmaceutical Industries Ltd.In forceHigh confidence
US 9,763,993Process for Manufacturing Glatiramer Acetate Product
In force
 · Medium confidence
Teva Pharmaceutical Industries, Ltd.In forceMedium confidence
Application 15/471,765Process for Manufacturing Glatiramer Acetate Product
Abandoned
Abandoned Jun 7, 2017
Teva Pharmaceutical Industries, Ltd.AbandonedAbandoned Jun 7, 2017
Application 15/510,156Process for Manufacturing Glatiramer Acetate Product
Abandoned
Abandoned May 1, 2018
Teva Pharmaceutical Industries Ltd.AbandonedAbandoned May 1, 2018
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Teva Pharmaceutical Industries, Ltd..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited